Newsfeeds Archive - Page 52 of 56

2 minute read

Study Reveals BetterLife’s LSD Analogue Boosts Structural Neuroplasticity Without Hallucinogenic Side Effects

August 24, 3:18 PM

A recent paper has provided new evidence that LSD has outstanding nootropic effects, believed to originate in the drug’s neuroplasticity promotion, in both animals and humans.

BETRF

2 minute read

Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know

By Lara Goldstein

August 24, 3:15 PM

Israeli-Canadian biotech psychedelics developer Clearmind Medicine Inc. (OTC Pink: CMNDF) together with clinical-stage cannabinoid pharma company SciSparc Ltd.

CMNDF

2 minute read

Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution

By Lara Goldstein

August 23, 5:13 PM

Biotech clinical-stage company Algernon Pharmaceuticals Inc.

AGNPF

2 minute read

GH Research Shares Q2 2022 Financial Results & Business Updates

By Lara Goldstein

August 23, 4:10 PM

GH Research PLC (NASDAQ: GHRS), the clinical-stage biopharma company dedicated to transforming the treatment of psychiatric and neurological disorders through 5-MeO-DMT production, provided a financial and business update for the quarter ended June 30, 2022.

GHRS

2 minute read

Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know

By Lara Goldstein

August 23, 7:30 AM

Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated.

BHVN

2 minute read

Awakn’s Second Licensing Partnership Agreement In A Week, This Time In Canada: Ketamine For Pain Comorbidities

By Lara Goldstein

August 18, 4:22 PM

Psychedelics therapeutics biotech company Awakn Life Sciences Corp. (OTCQB: AWKNF) has signed what constitutes its first licensing partnership deal in Canada.

AWKNF

2 minute read

Psychedelic Acquisition: Psycheceutical To Buy Majority Equity Stake In Maryland R&D Company

By Lara Goldstein

August 16, 4:51 PM

Publicly traded psychedelics company Psycheceutical Bioscience Inc. (OTC: BWVI) is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences’ majority equity stake.

BWVI

2 minute read

Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead

By Lara Goldstein

August 16, 4:36 PM

Optimi Health Corp.

OPTHF

2 minute read

Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder

By Lara Goldstein

August 16, 1:23 PM

Awakn Life Sciences Corp. (OTCQB: AWKNF), the biotech company focused on addiction treatments, has signed a licensing partnership agreement with US ketamine therapy clinics owner Revitalist Lifestyle and Wellness Ltd.

AWKNF

3 minute read

Who Are The Most Impactful Cannabis Executives Of 2022? Top Award Show Will Determine Who’s #1

By Lara Goldstein

August 16, 1:17 PM

After the awesome Cannabis Capital Conference in Miami during 4/20 week, Benzinga is ready to go again in Chicago on September 13-14.

CGC